Zoetis Inc.

Symbol: ZTS

NYSE

168.13

USD

Market price today

  • 32.2056

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 76.72B

    MRK Cap

  • 0.01%

    DIV Yield

Zoetis Inc. (ZTS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.69%

Operating Profit Margin

0.37%

Net Profit Margin

0.27%

Return on Assets

0.17%

Return on Equity

0.48%

Return on Capital Employed

0.26%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Ms. Kristin C. Peck
Full-time employees:14100
City:Parsippany
Address:10 Sylvan Way
IPO:2013-02-01
CIK:0001555280

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

General Outlook

When we look at how much money they make before expenses, they keep 0.692% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.368%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.274%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.167% return, is a testament to Zoetis Inc.'s adeptness in optimizing resource deployment. Zoetis Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.484%. Furthermore, the proficiency of Zoetis Inc. in capital utilization is underscored by a remarkable 0.259% return on capital employed.

Stock Prices

Zoetis Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $160.78, while its low point bottomed out at $158.04. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Zoetis Inc.'s stock market.

Liquidity Ratios

Analyzing ZTS liquidity ratios reveals its financial health of the firm. The current ratio of 333.11% gauges short-term asset coverage for liabilities. The quick ratio (171.19%) assesses immediate liquidity, while the cash ratio (103.46%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio333.11%
Quick Ratio171.19%
Cash Ratio103.46%

Profitability Ratios

ZTS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 34.19% underscores its earnings before tax deductions. The effective tax rate stands at 20.03%, revealing its tax efficiency. The net income per EBT, 80.07%, and the EBT per EBIT, 92.82%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 36.83%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin34.19%
Effective Tax Rate20.03%
Net Income per EBT80.07%
EBT per EBIT92.82%
EBIT per Revenue36.83%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.33, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 675.48% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding171
Days of Inventory Outstanding360
Operating Cycle413.74
Days of Payables Outstanding55
Cash Conversion Cycle359
Receivables Turnover6.75
Payables Turnover6.64
Inventory Turnover1.01
Fixed Asset Turnover2.51
Asset Turnover0.61

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 5.24, and free cash flow per share, 3.82, depict cash generation on a per-share basis. The cash per share value, 4.31, showcases liquidity position. A payout ratio of 0.30 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.27, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share5.24
Free Cash Flow per Share3.82
Cash per Share4.31
Payout Ratio0.30
Operating Cash Flow Sales Ratio0.27
Free Cash Flow to Operating Cash Flow Ratio0.73
Cash Flow Coverage Ratio0.36
Short Term Coverage Ratio99.96
Capital Expenditure Coverage Ratio3.70
Dividend Paid and Capex Coverage Ratio1.76
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 45.90%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.30, we discern the balance between debt and equity financing. The long-term debt to capitalization, 56.47%, and total debt to capitalization, 56.56%, ratios shed light on its capital structure. An interest coverage of 13.29 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio45.90%
Debt Equity Ratio1.30
Long Term Debt to Capitalization56.47%
Total Debt to Capitalization56.56%
Interest Coverage13.29
Cash Flow to Debt Ratio0.36
Company Equity Multiplier2.84

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 18.53, provides a glimpse into top-line earnings distributed across each share. Net income per share, 5.08, reflects the portion of profit attributed to each share. The book value per share, 10.84, represents the net asset value distributed per share, while the tangible book value per share, 1.94, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share18.53
Net Income Per Share5.08
Book Value Per Share10.84
Tangible Book Value Per Share1.94
Shareholders Equity Per Share10.84
Interest Debt Per Share14.96
Capex Per Share-1.59

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 5.74%, indicates top-line expansion, while the gross profit growth, 3.70%, reveals profitability trends. EBIT growth, 6.27%, and operating income growth, 6.27%, offer insights into operational profitability progression. The net income growth, 10.88%, showcases bottom-line expansion, and the EPS growth, 12.64%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth5.74%
Gross Profit Growth3.70%
EBIT Growth6.27%
Operating Income Growth6.27%
Net Income Growth10.88%
EPS Growth12.64%
EPS Diluted Growth12.92%
Weighted Average Shares Growth-1.65%
Weighted Average Shares Diluted Growth-1.73%
Dividends per Share Growth15.15%
Operating Cash Flow Growth23.06%
Free Cash Flow Growth22.25%
10-Year Revenue Growth per Share103.10%
5-Year Revenue Growth per Share53.64%
3-Year Revenue Growth per Share31.98%
10-Year Operating CF Growth per Share274.61%
5-Year Operating CF Growth per Share37.69%
3-Year Operating CF Growth per Share14.12%
10-Year Net Income Growth per Share404.24%
5-Year Net Income Growth per Share71.94%
3-Year Net Income Growth per Share47.55%
10-Year Shareholders Equity Growth per Share476.36%
5-Year Shareholders Equity Growth per Share139.55%
3-Year Shareholders Equity Growth per Share36.70%
10-Year Dividend per Share Growth per Share665.58%
5-Year Dividend per Share Growth per Share198.29%
3-Year Dividend per Share Growth per Share87.76%
Receivables Growth7.33%
Inventory Growth9.34%
Asset Growth-4.28%
Book Value per Share Growth15.34%
Debt Growth-15.91%
R&D Expense Growth13.91%
SGA Expenses Growth7.07%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 95,783,517,640, captures the company's total value, considering both debt and equity. Income quality, 1.00, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.22, gauges operational efficiency, while the research and development to revenue, 7.19%, highlights investment in innovation. The ratio of intangibles to total assets, 28.68%, indicates the value of non-physical assets, and capex to operating cash flow, -31.11%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value95,783,517,640
Income Quality1.00
Sales General and Administrative to Revenue0.22
Research and Development to Revenue7.19%
Intangibles to Total Assets28.68%
Capex to Operating Cash Flow-31.11%
Capex to Revenue-8.57%
Capex to Depreciation-149.08%
Stock-Based Compensation to Revenue0.70%
Graham Number35.20
Return on Tangible Assets23.01%
Graham Net Net-10.83
Working Capital4,454,000,000
Tangible Asset Value894,000,000
Net Current Asset Value-2,952,000,000
Invested Capital1
Average Receivables1,259,500,000
Average Payables408,000,000
Average Inventory2,454,500,000
Days Sales Outstanding56
Days Payables Outstanding55
Days of Inventory On Hand345
ROIC21.06%
ROE0.47%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 15.22, and the price to book ratio, 15.22, reflect the market's valuation relative to the company's book value. The price to sales ratio, 8.78, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 43.84, and price to operating cash flows, 32.10, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio15.22
Price to Book Ratio15.22
Price to Sales Ratio8.78
Price Cash Flow Ratio32.10
Enterprise Value Multiple20.16
Price Fair Value15.22
Price to Operating Cash Flow Ratio32.10
Price to Free Cash Flows Ratio43.84
Price to Tangible Book Ratio18.22
Enterprise Value to Sales11.21
Enterprise Value Over EBITDA26.91
EV to Operating Cash Flow40.71
Earnings Yield2.58%
Free Cash Flow Yield1.78%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Zoetis Inc. (ZTS) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 32.206 in 2024.

What is the ticker symbol of Zoetis Inc. stock?

The ticker symbol of Zoetis Inc. stock is ZTS.

What is company IPO date?

IPO date of Zoetis Inc. is 2013-02-01.

What is company current share price?

Current share price is 168.130 USD.

What is stock market cap today?

The market cap of stock today is 76716878350.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 14100.